<DOC>
	<DOC>NCT00044460</DOC>
	<brief_summary>The purpose of this study is to gain safety and efficacy information in patients with type 2 diabetes, who have not previously taken any oral antidiabetic medications, and who have an HbA1c value of greater than or equal to 10%, despite diet and exercise.</brief_summary>
	<brief_title>Efficacy and Safety In Poorly Controlled Type 2 Diabetics</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>Inclusion criteria: Type 2 diabetes Drugnaive. Laboratory test result for HbA1c of greater than or equal to 10%. Written informed consent. Exclusion criteria: Prior use of antidiabetic medications within 3 months of screening. Fluid retention (edema). Significant liver disease. Low red blood cells (anemia). Severe or unstable angina (chest pain). Congestive heart failure. Severe high blood pressure. Alcohol or drug abuse. Other inclusion or exclusion criteria to be determined by the physician and study sponsor.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Type 2 diabetes drug-naive</keyword>
</DOC>